July 25, 2022
  • Senator Amy Klobuchar, chair of the Senate Judiciary antitrust subcommittee, sent a letter to the Federal Trade Commission (FTC) regarding Amazon’s acquisition of One Medical. Klobuchar stated that the $3.9 billion deal “raises questions about potential anticompetitive effects related to the pharmacy services business Amazon already owns and about preferencing vendors who offer other services through Amazon.” (Article here)